Ping An Biomedical (PASW) CEO discloses 12.25M indirect share stake on Form 3

Rhea-AI Filing Summary

Ping An Biomedical Co., Ltd. CEO Liu Pijun has filed an initial statement of beneficial ownership. The filing shows that 12,250,000 Class A Ordinary Shares are held indirectly through INSPIRETECH LTD, reflecting a substantial position associated with the chief executive but does not report any recent share purchases or sales.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Liu Pijun (PJL)

Role CEO

Type	Security	Shares	Price	Value
holding	Class A Ordinary Shares	--	--	--

Holdings After Transaction: Class A Ordinary Shares — 12,250,000 shares (Indirect, Owner of INSPIRETECH LTD)

Footnotes (1)

Key Figures

Indirect share holding: 12,250,000 shares

1 metrics

Indirect share holding 12,250,000 shares Class A Ordinary Shares indirectly owned through INSPIRETECH LTD

Key Terms

Class A Ordinary Shares, indirect, Owner of INSPIRETECH LTD, beneficial ownership

4 terms

Class A Ordinary Shares financial

"security_title: "Class A Ordinary Shares""

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

indirect financial

"ownership_type: "indirect" and ownership_code: "I""

Owner of INSPIRETECH LTD financial

"nature_of_ownership: "Owner of INSPIRETECH LTD""

beneficial ownership financial

"initial statement of beneficial ownership"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Liu Pijun (PJL)

(Last) (First) (Middle)

ROOM 602, UNIT 3, BUILDING 19, PHASE 2,

CHAOBAI RENJIA, XINGGONG WEST STREET

(Street)

SANHE CITY, HEBEI PROVINCE 065200

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
10/14/2025

3. Issuer Name and Ticker or Trading Symbol
Ping An Biomedical Co., Ltd. [ PASW ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Ordinary Shares	12,250,000	I	Owner of INSPIRETECH LTD

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Pijun Liu	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Ping An Biomedical (PASW) Form 3 filing show?

The Form 3 shows CEO Liu Pijun’s initial beneficial ownership in Ping An Biomedical. It reports 12,250,000 Class A Ordinary Shares held indirectly through INSPIRETECH LTD, without indicating any recent purchases, sales, or derivative positions in the disclosed data.

How many Ping An Biomedical (PASW) shares are reported in this Form 3?

The filing reports 12,250,000 Class A Ordinary Shares. These shares are listed as indirectly owned, providing a snapshot of the CEO’s associated equity position at the time of the filing, rather than detailing any new transaction or change in ownership.

Is Liu Pijun’s ownership in Ping An Biomedical (PASW) direct or indirect?

The ownership is reported as indirect. The Form 3 states that the 12,250,000 Class A Ordinary Shares are held through INSPIRETECH LTD, meaning the position is attributed to an entity associated with Liu Pijun rather than being held in his personal name.

Does the Ping An Biomedical (PASW) Form 3 disclose any recent insider trades?

The Form 3 functions as an initial ownership report and does not list buy or sell transactions. It categorizes the entry as a holding, with transaction direction marked unknown, focusing solely on the 12,250,000 indirectly owned Class A Ordinary Shares.

What role does Liu Pijun hold at Ping An Biomedical (PASW)?

Liu Pijun is identified as both a director and the CEO of Ping An Biomedical. This dual role means the large indirect holding of 12,250,000 Class A Ordinary Shares reflects the equity position of a key executive and board member in the company.